THE THERAPEUTIC TREATMENT OF PEPITEM INCREASES THE PROTEIN EXPRESSION OF SIRT1 IN A MOUSE MODEL OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS (EAE) AS A MODEL FOR HUMAN MS
Received: 6th November 2023, Revised: 11th January 2024, 13th February 2024, Accepted: 29th February 2024, Date of Publication: 26th September 2024
DOI:
https://doi.org/10.20319/lijhls.2024.10.2636Keywords:
PEPITEM, Experimental Autoimmune Encephalomyelitis, SIRT1, Anti-InflammatoryAbstract
Objective: To investigate the effect of the prophylactic and therapeutic treatment of the immunopeptide PEPITEM on the protein expression of SIRT1 in a mouse model of experimental autoimmune encephalomyelitis (EAE) as a model for human MS.
Methods: Using C57BL/6 female mice, we dosed the PEPITEM in the EAE model via intraperitoneal injections either prophylactically or therapeutically. The disease was induced using MOG35-55 and complete Freund's adjuvants augmented with pertussis toxin. The EAE score was recorded daily until the end of the experiment (21 days). A Western blot analysis was performed on the brain lysate to measure the protein concentration of SIRT1.
Results: The therapeutic treatment with PEPITEM increased the protein expressions of SIRT1 on the EAE mice whereas the prophylactic injections did not affect the protein expression of SIRT1.
Conclusion: Collectively, the therapeutic treatment with PEPITEM suggesting anti-inflammatory effect of PEPITEM on the brain damage in EAE mice which offers a novel and safe strategy for drug therapy in MS, opening new avenues for research and treatment.
References
Abe-Higuchi, N., et al., Hippocampal Sirtuin 1 Signaling Mediates Depression-like Behavior. Biological Psychiatry, 2016. 80(11): p. 815-826.
Bradbury, C.A., et al., Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia, 2005. 19(10): p. 1751-1759.
Cheng, Y., et al., Sirtuin 1 attenuates oxidative stress via upregulation of superoxide dismutase 2 and catalase in astrocytes. Journal of Neuroimmunology, 2014. 269(1): p. 38-43.
Chimen, M., et al., Homeostatic regulation of T cell trafficking by a B cell-derived peptide is impaired in autoimmune and chronic inflammatory disease. Nat Med, 2015. 21(5): p. 467-475.
Cho, S.-H., et al., SIRT1 Deficiency in Microglia Contributes to Cognitive Decline in Aging and Neurodegeneration via Epigenetic Regulation of IL-1β. The Journal of Neuroscience, 2015. 35(2): p. 807-818.
Croft, A.P., et al., 246. PROPHYLACTIC TREATMENT WITH PEPITEM INHIBITS ONSET OF COLLAGEN-INDUCED ARTHRITIS AND THERAPEUTICALLY PEPITEM REDUCES DISEASE SEVERITY. Rheumatology, 2017. 56(suppl_2).
Deng, C.X., SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci, 2009. 5(2): p. 147-52.
Huffman, D.M., et al., SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res, 2007. 67(14): p. 6612-8.
Leray, E., et al., Epidemiology of multiple sclerosis. Rev Neurol (Paris), 2016. 172(1): p. 3-13.
Lu, G., et al., Role and Possible Mechanisms of Sirt1 in Depression. Oxidative Medicine and Cellular Longevity, 2018. 2018: p. 8596903.
Mohamed, G.A., et al., Cucurbitacin E glucoside alleviates concanavalin A-induced hepatitis through enhancing SIRT1/Nrf2/HO-1 and inhibiting NF-ĸB/NLRP3 signaling pathways. J Ethnopharmacol, 2022. 292: p. 115223.
Mohammed, E.M.A., Multiple sclerosis is prominent in the Gulf states: Review. Pathogenesis, 2016. 3(2): p. 19-38.
Pezhman, L., et al., PEPITEM modulates leukocyte trafficking to reduce obesity-induced inflammation. Clin Exp Immunol, 2023. 212(1): p. 1-10.
Rahman, S. and R. Islam, Mammalian Sirt1: insights on its biological functions. Cell Commun Signal, 2011. 9: p. 11.
Stünkel, W., et al., Function of the SIRT1 protein deacetylase in cancer. Biotechnol J, 2007. 2(11): p. 1360-8.
Tran, E.H., et al., Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol, 1998. 161(7): p. 3767-75.
Wei, L., et al., The SIRT1-HMGB1 axis: Therapeutic potential to ameliorate inflammatory responses and tumor occurrence. Frontiers in Cell and Developmental Biology, 2022. 10.
Xie, J., X. Zhang, and L. Zhang, Negative regulation of inflammation by SIRT1. Pharmacological Research, 2013. 67(1): p. 60-67.
Yoshizaki, T., et al., SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes. Mol Cell Biol, 2009. 29(5): p. 1363-74.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright of Published Articles
Author(s) retain the article copyright and publishing rights without any restrictions.
All published work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
